Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Myriad Genetics Inc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 223 | 2 | 246 | +25 |
| Shares | 92.2M | 15.2M | 90.7M | +13.8M (+17.9%) |
| Value | $2.25B | $372.9M | $2.48B | +$601.5M (+32.0%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (48)
Institutions that held Myriad Genetics Inc at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (23)
Institutions that held Myriad Genetics Inc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Eversept Partners, LP | 181,961 | $4.45M |
| ExodusPoint Capital Management, LP | 170,287 | $4.17M |
| Voloridge Investment Management, LLC | 84,660 | $2.07M |
| Moore Capital Management, LP | 60,000 | $1.47M |
| Maven Securities LTD | 50,000 | $1.22M |
| Caption Management, LLC | 38,300 | $936.8K |
| UniSuper Management Pty Ltd | 21,917 | $536.1K |
| Campbell & CO Investment Adviser LLC | 21,617 | $528.8K |
| Bayesian Capital Management, LP | 19,400 | $474.5K |
| Vident Advisory, LLC | 10,848 | $265.3K |
| Two Sigma Advisers, LP | 10,800 | $264.2K |
| Neo Ivy Capital Management | 3,488 | $85.0K |
| Catalyst Funds Management Pty Ltd | 3,200 | $78.3K |
| Simplex Trading, LLC | 1,985 | $48.0K |
| Innealta Capital, LLC | 1,466 | $35.9K |
| Tompkins Financial Corp | 840 | $20.5K |
| Pacer Advisors, Inc. | 532 | $13.0K |
| Itau Unibanco Holding S.A. | 203 | $4.96K |
| Sittner & Nelson, LLC | 150 | $3.67K |
| Cullen/Frost Bankers, Inc. | 74 | $1.81K |
| Kelly Financial Services LLC | 60 | $1.47K |
| Johnson Financial Group, Inc. | 36 | $881 |
| Mather Group, LLC. | 3 | $64 |
Not filed for Q3 2024 yet (2)
Institutions that held Myriad Genetics Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 15,150,806 | $370.6M |
| Susquehanna Fundamental Investments, LLC | 94,624 | $2.31M |